SU511852A3 - Способ получени пептидов - Google Patents

Способ получени пептидов

Info

Publication number: SU511852A3
Authority: SU; USSR - Soviet Union
Prior art keywords: solution; hydroxy; water; residue; ether
Prior art date: 1971-07-01

Application number

SU1803547A

Other languages

English (en)

Russian (ru)

Inventor

Кениг Вольфганг

Гейгер Рольф

Виссманн Ханс

Original Assignee

Хехст Аг (Фирма)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-07-01

Filing date

1972-06-29

Publication date

1976-04-25

1971-07-01 Priority claimed from DE19712132767 external-priority patent/DE2132767A1/de

1972-01-20 Priority claimed from DE2202613A external-priority patent/DE2202613C3/de

1972-06-29 Application filed by Хехст Аг (Фирма) filed Critical Хехст Аг (Фирма)

1976-04-25 Application granted granted Critical

1976-04-25 Publication of SU511852A3 publication Critical patent/SU511852A3/ru

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims description 17
238000000034 method Methods 0.000 title claims description 16
102000004196 processed proteins & peptides Human genes 0.000 title claims description 10
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 156
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 110
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 99
239000000243 solution Substances 0.000 claims description 98
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 72
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
239000000047 product Substances 0.000 claims description 49
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 48
239000000203 mixture Substances 0.000 claims description 36
-1 Boc-amino Chemical group 0.000 claims description 31
235000019439 ethyl acetate Nutrition 0.000 claims description 26
239000002244 precipitate Substances 0.000 claims description 22
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
229960000583 acetic acid Drugs 0.000 claims description 20
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
238000003756 stirring Methods 0.000 claims description 18
HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 claims description 17
230000015572 biosynthetic process Effects 0.000 claims description 17
150000001875 compounds Chemical class 0.000 claims description 17
239000000126 substance Substances 0.000 claims description 17
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 16
238000000354 decomposition reaction Methods 0.000 claims description 16
239000000706 filtrate Substances 0.000 claims description 16
238000006243 chemical reaction Methods 0.000 claims description 15
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 14
PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims description 14
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
239000003054 catalyst Substances 0.000 claims description 12
239000012362 glacial acetic acid Substances 0.000 claims description 12
238000003786 synthesis reaction Methods 0.000 claims description 12
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 11
229910052938 sodium sulfate Inorganic materials 0.000 claims description 11
235000011152 sodium sulphate Nutrition 0.000 claims description 11
150000001413 amino acids Chemical class 0.000 claims description 10
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 9
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 9
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
229910052739 hydrogen Inorganic materials 0.000 claims description 7
238000000746 purification Methods 0.000 claims description 7
239000011347 resin Substances 0.000 claims description 7
229920005989 resin Polymers 0.000 claims description 7
229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 7
235000017557 sodium bicarbonate Nutrition 0.000 claims description 7
235000011121 sodium hydroxide Nutrition 0.000 claims description 7
239000002904 solvent Substances 0.000 claims description 7
238000004809 thin layer chromatography Methods 0.000 claims description 7
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
239000001257 hydrogen Substances 0.000 claims description 6
230000003993 interaction Effects 0.000 claims description 6
238000005406 washing Methods 0.000 claims description 6
125000005842 heteroatom Chemical group 0.000 claims description 5
239000012071 phase Substances 0.000 claims description 5
229920000642 polymer Polymers 0.000 claims description 5
239000007790 solid phase Substances 0.000 claims description 5
239000000725 suspension Substances 0.000 claims description 5
125000000217 alkyl group Chemical group 0.000 claims description 4
239000012141 concentrate Substances 0.000 claims description 4
238000001816 cooling Methods 0.000 claims description 4
239000011521 glass Substances 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims description 4
239000011541 reaction mixture Substances 0.000 claims description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical group CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
125000003277 amino group Chemical group 0.000 claims description 3
238000004458 analytical method Methods 0.000 claims description 3
125000003118 aryl group Chemical group 0.000 claims description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
239000000460 chlorine Substances 0.000 claims description 3
229910052801 chlorine Inorganic materials 0.000 claims description 3
239000000463 material Substances 0.000 claims description 3
239000012074 organic phase Substances 0.000 claims description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
229910000343 potassium bisulfate Inorganic materials 0.000 claims description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
239000008346 aqueous phase Substances 0.000 claims description 2
238000001035 drying Methods 0.000 claims description 2
150000002170 ethers Chemical class 0.000 claims description 2
238000002474 experimental method Methods 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
125000006501 nitrophenyl group Chemical group 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
238000004587 chromatography analysis Methods 0.000 claims 2
238000001914 filtration Methods 0.000 claims 2
125000000623 heterocyclic group Chemical group 0.000 claims 2
NPWMTBZSRRLQNJ-VKHMYHEASA-N (3s)-3-aminopiperidine-2,6-dione Chemical group N[C@H]1CCC(=O)NC1=O NPWMTBZSRRLQNJ-VKHMYHEASA-N 0.000 claims 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
QVWDCUMRWIBGJX-UHFFFAOYSA-N 1-hydroxy-4,6-dimethylpyridin-2-one Chemical compound CC=1C=C(C)N(O)C(=O)C=1 QVWDCUMRWIBGJX-UHFFFAOYSA-N 0.000 claims 1
LOKDIDVKVVVVHK-UHFFFAOYSA-N 3-hydroxy-4-methyl-1,3-thiazole-2-thione Chemical compound CC1=CSC(=S)N1O LOKDIDVKVVVVHK-UHFFFAOYSA-N 0.000 claims 1
JWPXVTUMRCJDJW-UHFFFAOYSA-N 3-hydroxy-4h-1,2,3-benzotriazin-4-ol Chemical compound C1=CC=C2C(O)N(O)N=NC2=C1 JWPXVTUMRCJDJW-UHFFFAOYSA-N 0.000 claims 1
SKAYLCIAMUNIHK-UHFFFAOYSA-N 3-hydroxyquinazolin-4-one Chemical compound C1=CC=C2C(=O)N(O)C=NC2=C1 SKAYLCIAMUNIHK-UHFFFAOYSA-N 0.000 claims 1
UNCQQOQXSVYKLZ-UHFFFAOYSA-N CC1=C(C(=O)NC(=C1Cl)C)Cl Chemical compound CC1=C(C(=O)NC(=C1Cl)C)Cl UNCQQOQXSVYKLZ-UHFFFAOYSA-N 0.000 claims 1
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims 1
229920005654 Sephadex Polymers 0.000 claims 1
239000012507 Sephadex™ Substances 0.000 claims 1
LDKDGDIWEUUXSH-UHFFFAOYSA-N Thymophthalein Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C LDKDGDIWEUUXSH-UHFFFAOYSA-N 0.000 claims 1
238000005903 acid hydrolysis reaction Methods 0.000 claims 1
125000002252 acyl group Chemical group 0.000 claims 1
230000006229 amino acid addition Effects 0.000 claims 1
BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 claims 1
238000004939 coking Methods 0.000 claims 1
239000012043 crude product Substances 0.000 claims 1
238000002425 crystallisation Methods 0.000 claims 1
230000008025 crystallization Effects 0.000 claims 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
230000007717 exclusion Effects 0.000 claims 1
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 claims 1
238000001802 infusion Methods 0.000 claims 1
238000002955 isolation Methods 0.000 claims 1
XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 claims 1
238000006386 neutralization reaction Methods 0.000 claims 1
150000002923 oximes Chemical class 0.000 claims 1
CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 claims 1
238000001556 precipitation Methods 0.000 claims 1
238000011085 pressure filtration Methods 0.000 claims 1
238000010992 reflux Methods 0.000 claims 1
239000001632 sodium acetate Substances 0.000 claims 1
235000017281 sodium acetate Nutrition 0.000 claims 1
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical class C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 26
239000003208 petroleum Substances 0.000 description 15
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 13
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 9
229940125396 insulin Drugs 0.000 description 8
150000002148 esters Chemical class 0.000 description 7
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
102000004877 Insulin Human genes 0.000 description 6
108090001061 Insulin Proteins 0.000 description 6
235000001014 amino acid Nutrition 0.000 description 6
229940024606 amino acid Drugs 0.000 description 6
230000035484 reaction time Effects 0.000 description 6
SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 description 5
239000002253 acid Substances 0.000 description 5
230000006340 racemization Effects 0.000 description 5
YBNRHMJGYWCQIJ-UHFFFAOYSA-N 1-hydroxy-5,6-dimethylbenzotriazole Chemical compound C1=C(C)C(C)=CC2=C1N(O)N=N2 YBNRHMJGYWCQIJ-UHFFFAOYSA-N 0.000 description 4
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
230000008033 biological extinction Effects 0.000 description 4
235000018417 cysteine Nutrition 0.000 description 4
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
238000001953 recrystallisation Methods 0.000 description 4
159000000000 sodium salts Chemical class 0.000 description 4
RRONHWAVOYADJL-HNNXBMFYSA-N (2s)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 RRONHWAVOYADJL-HNNXBMFYSA-N 0.000 description 3
AFXHVMLWGXYZJA-UHFFFAOYSA-N 1-hydroxy-4-methylpyridin-2-one Chemical compound CC=1C=CN(O)C(=O)C=1 AFXHVMLWGXYZJA-UHFFFAOYSA-N 0.000 description 3
SIQXGSXHNVEPDX-UHFFFAOYSA-N 1-hydroxy-6-methoxybenzotriazole Chemical compound COC1=CC=C2N=NN(O)C2=C1 SIQXGSXHNVEPDX-UHFFFAOYSA-N 0.000 description 3
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
150000008064 anhydrides Chemical class 0.000 description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
238000004090 dissolution Methods 0.000 description 3
238000005259 measurement Methods 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
229940086542 triethylamine Drugs 0.000 description 3
XYXYXSKSTZAEJW-VIFPVBQESA-N (2s)-2-(phenylmethoxycarbonylamino)butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 XYXYXSKSTZAEJW-VIFPVBQESA-N 0.000 description 2
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
XMUAGMCFZMDQTI-UHFFFAOYSA-N 1-hydroxy-5-methylbenzotriazole Chemical compound CC1=CC=C2N(O)N=NC2=C1 XMUAGMCFZMDQTI-UHFFFAOYSA-N 0.000 description 2
GKNOMEOXEUNEKT-UHFFFAOYSA-N 1h-pyridin-2-one;sodium Chemical compound [Na].OC1=CC=CC=N1 GKNOMEOXEUNEKT-UHFFFAOYSA-N 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
239000000654 additive Substances 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
239000007859 condensation product Substances 0.000 description 2
SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
239000012467 final product Substances 0.000 description 2
150000002440 hydroxy compounds Chemical class 0.000 description 2
239000012188 paraffin wax Substances 0.000 description 2
229960005190 phenylalanine Drugs 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
150000003246 quinazolines Chemical class 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000007017 scission Effects 0.000 description 2
239000007858 starting material Substances 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
TYZYNGFWGHGRBZ-REOHCLBHSA-N (2s)-2-(chloroamino)propanoic acid Chemical compound ClN[C@@H](C)C(O)=O TYZYNGFWGHGRBZ-REOHCLBHSA-N 0.000 description 1
125000006569 (C5-C6) heterocyclic group Chemical group 0.000 description 1
AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
ATIMVMORQPKRPC-UHFFFAOYSA-N 1,2,3-trichloro-4-(2,3,4-trichlorophenoxy)benzene Chemical class ClC1=C(Cl)C(Cl)=CC=C1OC1=CC=C(Cl)C(Cl)=C1Cl ATIMVMORQPKRPC-UHFFFAOYSA-N 0.000 description 1
QEASJVYPHMYPJM-UHFFFAOYSA-N 1,2-dihydrotriazol-5-one Chemical compound OC1=CNN=N1 QEASJVYPHMYPJM-UHFFFAOYSA-N 0.000 description 1
FAGBXROYNNGHJC-UHFFFAOYSA-N 1-hydroxy-3,4,6-trimethylpyridin-2-one Chemical compound CC=1C=C(C)N(O)C(=O)C=1C FAGBXROYNNGHJC-UHFFFAOYSA-N 0.000 description 1
FAUXYQYNBHEGDG-UHFFFAOYSA-N 1-hydroxy-4-methylbenzotriazole Chemical compound CC1=CC=CC2=C1N=NN2O FAUXYQYNBHEGDG-UHFFFAOYSA-N 0.000 description 1
PEFBAFXTCWVHCL-UHFFFAOYSA-N 1-hydroxy-6-methylbenzotriazole Chemical compound CC1=CC=C2N=NN(O)C2=C1 PEFBAFXTCWVHCL-UHFFFAOYSA-N 0.000 description 1
XXRXCJAZZQPWIM-UHFFFAOYSA-N 1-hydroxybenzotriazole;sodium Chemical compound [Na].C1=CC=C2N(O)N=NC2=C1 XXRXCJAZZQPWIM-UHFFFAOYSA-N 0.000 description 1
FQKFPGMGQXQHLP-UHFFFAOYSA-N 1-hydroxytriazole Chemical compound ON1C=CN=N1 FQKFPGMGQXQHLP-UHFFFAOYSA-N 0.000 description 1
XVIRIXVOLLJIPF-UHFFFAOYSA-N 1-nitro-2-(2-nitrophenoxy)benzene Chemical compound [O-][N+](=O)C1=CC=CC=C1OC1=CC=CC=C1[N+]([O-])=O XVIRIXVOLLJIPF-UHFFFAOYSA-N 0.000 description 1
HSQFVBWFPBKHEB-UHFFFAOYSA-N 2,3,4-trichlorophenol Chemical compound OC1=CC=C(Cl)C(Cl)=C1Cl HSQFVBWFPBKHEB-UHFFFAOYSA-N 0.000 description 1
YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
CGACGSHTSCXSSO-UHFFFAOYSA-N 2h-1,3-benzoxazine Chemical class C1=CC=C2C=NCOC2=C1 CGACGSHTSCXSSO-UHFFFAOYSA-N 0.000 description 1
JBQWQBSRIAGTJT-UHFFFAOYSA-N 3-ethylmorpholine Chemical compound CCC1COCCN1 JBQWQBSRIAGTJT-UHFFFAOYSA-N 0.000 description 1
HJBLUNHMOKFZQX-UHFFFAOYSA-N 3-hydroxy-1,2,3-benzotriazin-4-one Chemical compound C1=CC=C2C(=O)N(O)N=NC2=C1 HJBLUNHMOKFZQX-UHFFFAOYSA-N 0.000 description 1
CTJKRKMPTRJAIT-AATRIKPKSA-N 4-[(e)-2-nitroethenyl]phenol Chemical compound OC1=CC=C(\C=C\[N+]([O-])=O)C=C1 CTJKRKMPTRJAIT-AATRIKPKSA-N 0.000 description 1
KCOPVBJLGFRNOG-UHFFFAOYSA-N 5-chloro-1-hydroxybenzotriazole Chemical compound ClC1=CC=C2N(O)N=NC2=C1 KCOPVBJLGFRNOG-UHFFFAOYSA-N 0.000 description 1
TZCYLJGNWDVJRA-UHFFFAOYSA-N 6-chloro-1-hydroxybenzotriazole Chemical compound C1=C(Cl)C=C2N(O)N=NC2=C1 TZCYLJGNWDVJRA-UHFFFAOYSA-N 0.000 description 1
101100288076 Arabidopsis thaliana TK1A gene Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
DQYAPJJSRBXEPZ-UHFFFAOYSA-N ClC(=O)O.C(C(C)C)OCC(C)C Chemical compound ClC(=O)O.C(C(C)C)OCC(C)C DQYAPJJSRBXEPZ-UHFFFAOYSA-N 0.000 description 1
LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
229940122920 Kallikrein inhibitor Drugs 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
KDLSAOBXTJCDID-UHFFFAOYSA-N ON1C(NC2=CC=CC=C2C1)=O Chemical compound ON1C(NC2=CC=CC=C2C1)=O KDLSAOBXTJCDID-UHFFFAOYSA-N 0.000 description 1
108010086019 Secretin Proteins 0.000 description 1
102100037505 Secretin Human genes 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
MTEUMURLJRZUKD-UHFFFAOYSA-N acetic acid;butan-1-ol;pyridine;hydrate Chemical compound O.CC(O)=O.CCCCO.C1=CC=NC=C1 MTEUMURLJRZUKD-UHFFFAOYSA-N 0.000 description 1
125000004442 acylamino group Chemical group 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
150000001371 alpha-amino acids Chemical class 0.000 description 1
235000008206 alpha-amino acids Nutrition 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
125000003710 aryl alkyl group Chemical group 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
239000012964 benzotriazole Substances 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
238000009835 boiling Methods 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000004148 curcumin Substances 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
229960003067 cystine Drugs 0.000 description 1
AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
230000000694 effects Effects 0.000 description 1
DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
229960004578 ethylmorphine Drugs 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000001879 gelation Methods 0.000 description 1
125000005179 haloacetyl group Chemical group 0.000 description 1
125000004970 halomethyl group Chemical group 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000008274 jelly Substances 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
NEVPGZLSKXATIM-UHFFFAOYSA-N n-dimethoxyphosphoryl-n-methylmethanamine Chemical compound COP(=O)(OC)N(C)C NEVPGZLSKXATIM-UHFFFAOYSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000007530 organic bases Chemical group 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
238000004816 paper chromatography Methods 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
239000004033 plastic Substances 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
229920005990 polystyrene resin Polymers 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
238000013138 pruning Methods 0.000 description 1
UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
229960002101 secretin Drugs 0.000 description 1
OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
238000001665 trituration Methods 0.000 description 1
238000002211 ultraviolet spectrum Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/10—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
- C07K1/124—Hydrazinolysis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SU1803547A 1971-07-01 1972-06-29 Способ получени пептидов SU511852A3 (ru)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19712132767 DE2132767A1 (de)	1971-07-01	1971-07-01	Verfahren zur herstellung von peptiden
DE2202613A DE2202613C3 (de)	1972-01-20	1972-01-20	Verfahren zur Herstellung von Peptiden

Publications (1)

Publication Number	Publication Date
SU511852A3 true SU511852A3 (ru)	1976-04-25

Family

ID=25761356

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SU1803547A SU511852A3 (ru)	1971-07-01	1972-06-29	Способ получени пептидов

Country Status (12)

Country	Link
JP (1)	JPS5110201B1 (fr)
AT (1)	AT340067B (fr)
BE (1)	BE785790A (fr)
CA (1)	CA988079A (fr)
DD (1)	DD99570A5 (fr)
DK (1)	DK145715C (fr)
FR (1)	FR2144416A5 (fr)
GB (1)	GB1396801A (fr)
HU (1)	HU169326B (fr)
IL (1)	IL39788A (fr)
NL (1)	NL176255C (fr)
SU (1)	SU511852A3 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262230B1 (en) *	1994-01-28	2001-07-17	Sciclone Pharmaceuticals Inc.	Analogs of thymosin α1
KR102571783B1 (ko) *	2022-12-16	2023-08-29	스트라토 주식회사	대용량 검색 처리를 수행하는 검색 처리 시스템 및 그 제어방법

1972
- 1972-06-26 NL NLAANVRAGE7208757,A patent/NL176255C/xx not_active IP Right Cessation
- 1972-06-26 CA CA145,655A patent/CA988079A/en not_active Expired
- 1972-06-29 IL IL39788A patent/IL39788A/xx unknown
- 1972-06-29 SU SU1803547A patent/SU511852A3/ru active
- 1972-06-30 AT AT565672A patent/AT340067B/de not_active IP Right Cessation
- 1972-06-30 DD DD164093A patent/DD99570A5/xx unknown
- 1972-06-30 DK DK328672A patent/DK145715C/da not_active IP Right Cessation
- 1972-06-30 FR FR7223802A patent/FR2144416A5/fr not_active Expired
- 1972-06-30 HU HUHO1495A patent/HU169326B/hu unknown
- 1972-07-01 JP JP47066215A patent/JPS5110201B1/ja active Pending
- 1972-07-03 BE BE785790D patent/BE785790A/fr not_active IP Right Cessation
- 1972-07-03 GB GB3098472A patent/GB1396801A/en not_active Expired

Also Published As

Publication number	Publication date
NL7208757A (fr)	1973-01-03
IL39788A0 (en)	1972-08-30
IL39788A (en)	1976-07-30
BE785790A (fr)	1973-01-03
JPS5110201B1 (fr)	1976-04-02
DK145715B (da)	1983-02-07
CA988079A (en)	1976-04-27
ATA565672A (de)	1977-03-15
HU169326B (en)	1976-11-27
NL176255B (nl)	1984-10-16
DK145715C (da)	1983-08-08
DD99570A5 (fr)	1973-08-12
NL176255C (nl)	1985-03-18
AT340067B (de)	1977-11-25
GB1396801A (en)	1975-06-04
FR2144416A5 (fr)	1973-02-09

Publication	Publication Date	Title
Barlos et al.	1982	Efficient" one-pot" synthesis of N-tritylamino acids
Yang et al.	1976	. beta.-Phenacyl ester as a temporary protecting group to minimize cyclic imide formation during subsequent treatment of aspartyl peptides with hydrofluoric acid
AU741216B2 (en)	2001-11-29	Phenethylamine derivatives
US4242329A (en)	1980-12-30	Bradykinin-inhibiting tripeptide derivatives
JPS63284197A (ja)	1988-11-21	ホスホリパーゼａ↓２‐阻止作用を有するペプチド
HU182866B (en)	1984-03-28	Process for preparing new tetrapeptide derivatives
IE54226B1 (en)	1989-07-19	Renally active dipeptides
US4092304A (en)	1978-05-30	4-Substituted enkephalin derivatives
JPS5936611B2 (ja)	1984-09-05	ペプチドの製造方法
US3749703A (en)	1973-07-31	Asn15-bovine thyrocalcitonin
EP0292729A2 (fr)	1988-11-30	Procédé de synthèse de peptides en phase solide
CN117003791B (zh)	2025-06-27	一种二苯基膦酰氧基双酚a类化合物及其制备美白九肽-1中的应用
DE2202613A1 (de)	1973-08-30	Verfahren zur herstellung von peptiden
US4204991A (en)	1980-05-27	Sarcosine1 dehydroalanine8 angiotensin II derivatives
CA1244008A (fr)	1988-11-01	Synthese de l'aspartame
JPH0578394A (ja)	1993-03-30	フコースで標識した細胞増殖抑制物質
US3247180A (en)	1966-04-19	Nonadecapeptides and intermediates for the preparation thereof
SU659083A3 (ru)	1979-04-25	Способ получени сульфата октапептидамида-терминального октапетида холецистокининпанкреазимина
US4152322A (en)	1979-05-01	Process for selective reduction of nitroarginyl peptides with titanium (iii)
RU2063979C1 (ru)	1996-07-20	Пептиды последовательности окситоцина
US3948971A (en)	1976-04-06	N-protected-α-amino acid compounds
Sakiyama	1962	Synthesis of Histidyl Peptides. II. Synthesis and Properties of Dicarbobenzyloxyhistidylamino Acid Esters
CA1131217A (fr)	1982-09-07	Peptides psycho-pharmacologiques
DE3841732A1 (de)	1990-06-13	Dipeptid-derivate mit enzym-inhibitorischer wirkung
US3812092A (en)	1974-05-21	Intermediates in the preparation of secretin